Infectious Diseases News
🇺🇸 FDAFDA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–7 of 7 articles
Eli Lilly's $3.8B Investment in Infectious Disease Portfolio
FDA Grants Priority Review for Gilead's Bictegravir Plus Lenacapavir HIV Treatment Combination
Emergent BioSolutions Partners with Substipharm for $34.5M Japanese Encephalitis Vaccine Manufacturing Deal
Novartis Coartem Baby Receives WHO Prequalification as First Malaria Treatment for Newborns
APHL 2026 Annual: Public Health Lab Trends in Baltimore
FDA Approves Merck's IDVYNSO: First Non-INSTI, Tenofovir-Free Two-Drug HIV Treatment
Elion Therapeutics Launches Phase 2 Trial for Turletricin (EL219) in Invasive Mold Infections